Search results
Mar 25, 2024 · Paxlovid, an oral antiviral pill that can be taken at home, is the go-to treatment for COVID-19. If you are at high risk for severe disease from COVID, and you take it within the first five days of experiencing symptoms, it will lower your risk of getting so sick that you need to be hospitalized.
PAXLOVID is only available by prescription and must be started within the first 5 days of COVID‑19 symptoms. Here are some key steps for working with your healthcare professional to determine if PAXLOVID may be right for you.
• The antiviral drug Paxlovid (ritonavir-boosted nirmatrelvir) and Veklury (remdesivir), are the preferred treatments for eligible adult and pediatric patients with current diagnosis of mild-to-moderate COVID-19 and who are at risk for progression to severe COVID-19.
Jun 8, 2023 · Paxlovid is a combination of two antiviral tablets that’s FDA approved to treat mild to moderate COVID in adults. It’s also authorized for use in certain adolescents ages 12 and older. You may qualify for a Paxlovid prescription directly from your pharmacist without having to see a healthcare provider.
Jan 29, 2024 · Patients who have a prescription for Paxlovid will continue to receive either EUA-labeled or NDA-labeled Paxlovid through March 8, 2024. After that date, they will receive...
6 days ago · If you test positive for COVID and have a primary care provider who knows your recent medical history, start by asking them if you can get Paxlovid. If your provider thinks the drug is right for you, they can call a prescription into your local pharmacy and you can pick it up.
Walgreens pharmacists can now prescribe Paxlovid to help treat COVID-19. Learn more today and see if you are eligible for the antiviral treatment.
Patients can receive a prescription for Paxlovid by three main ways: a health care provider, a Test to Treat site, or an authorized pharmacist. An individual’s health care provider remains the best first option for assessment and prescribing for patients who have symptoms consistent with mild to moderate COVID-19.
Paxlovid is authorized for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms or about 88 pounds) with positive results of direct SARS-CoV-2 viral testing, who are at high risk for progression to severe COVID-19, including hospitalization or death.
May 4, 2022 · FDA authorized Paxlovid (nirmatrelvir and ritonavir) in December 2021 for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least...
